Literature DB >> 34374736

COVID-19 mRNA Vaccines Blunt Breakthrough Infection Severity.

Jennifer Abbasi.   

Abstract

Entities:  

Year:  2021        PMID： 34374736     DOI： 10.1001/jama.2021.12619

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  GMI, a protein from Ganoderma microsporum, induces ACE2 degradation to alleviate infection of SARS-CoV-2 Spike-pseudotyped virus.

Authors:  Hsin Yeh; Di Ngoc Kha Vo; Zhi-Hu Lin; Ha Phan Thanh Ho; Wei-Jyun Hua; Wei-Lun Qiu; Ming-Han Tsai; Tung-Yi Lin
Journal:  Phytomedicine       Date:  2022-05-28       Impact factor: 6.656

2.  Comparison of severity of immunized versus non-immunized COVID-19 patients admitted to ICU: A prospective observational study.

Authors:  Huda Mhawish; Ahmed Mady; Faisal Alaklobi; Waleed Aletreby; Tasmiya Asad; Mohammed Alodat; Abdulrahman Alharthy; Basheer Abdulrahman; Saleh Almahwi; Ziad A Memish
Journal:  Ann Med Surg (Lond)       Date:  2021-10-15

Review 3.  Potentials of Neuropeptides as Therapeutic Agents for Neurological Diseases.

Authors:  Xin Yi Yeo; Grace Cunliffe; Roger C Ho; Su Seong Lee; Sangyong Jung
Journal:  Biomedicines       Date:  2022-02-01

Review 4.  COVID-19 Vaccine Anaphylaxis: Current Evidence and Future Approaches.

Authors:  Wannada Laisuan
Journal:  Front Allergy       Date:  2021-12-23

5.  The Severity of COVID 19 Pneumonia in Vaccinated vs. Non-vaccinated Patients in the Second Wave: An Experience From a Tertiary Care Center in India.

Authors:  Jyoti Bajpai; Surya Kant; Ajay Verma; Ajay K Patwa; Virendra Atam; Shyam C Chaudhary; Anuj Pandey
Journal:  Cureus       Date:  2022-05-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.